Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer have?
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer has 8,040 citations in the OpenAlex counts ScholarIQ stores.
When was Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer published?
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer has 2012 year in the ScholarIQ index.
What is the open-access status of Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer?
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer?
The DOI for Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer is on the source record.
What is the PMID of Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer?
The PMID for Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer is on the source record.
What is the OpenAlex record for Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer?
The OpenAlex for Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer is on the source record.